1.32
Schlusskurs vom Vortag:
$1.30
Offen:
$1.3
24-Stunden-Volumen:
3.26M
Relative Volume:
1.45
Marktkapitalisierung:
$1.01B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-6.9474
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
+3.13%
1M Leistung:
-10.81%
6M Leistung:
+1.54%
1J Leistung:
-15.38%
Opko Health Inc Stock (OPK) Company Profile
Firmenname
Opko Health Inc
Sektor
Branche
Telefon
305-575-4181
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Vergleichen Sie OPK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
OPK
Opko Health Inc
|
1.32 | 998.01M | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | JP Morgan | Neutral |
| 2025-10-31 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-25 | Eingeleitet | JP Morgan | Neutral |
| 2023-06-29 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-24 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-11-25 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Bestätigt | Standpoint Research | Buy |
| 2016-06-03 | Eingeleitet | Standpoint Research | Buy |
| 2016-03-31 | Bestätigt | Barrington Research | Outperform |
| 2015-10-16 | Eingeleitet | JP Morgan | Overweight |
| 2015-09-11 | Herabstufung | Jefferies | Buy → Hold |
| 2015-03-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Bestätigt | Oppenheimer | Outperform |
| 2014-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2013-11-13 | Bestätigt | Ladenburg Thalmann | Buy |
| 2013-05-30 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-10-22 | Eingeleitet | Barrington Research | Outperform |
| 2011-12-01 | Bestätigt | Ladenburg Thalmann | Buy |
| 2011-07-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Opko Health Inc Aktie (OPK) Neueste Nachrichten
OPKO Health (NASDAQ:OPK) CEO Acquires $771,400.00 in Stock - MarketBeat
Zacks Research Boosts Earnings Estimates for OPKO Health - MarketBeat
OPKO Health (NASDAQ:OPK) Earns Neutral Rating from Analysts at JPMorgan Chase & Co. - MarketBeat
Will OPKO Health Inc. (XCY) stock attract long term capital inflowsJuly 2025 Summary & Daily Price Action Insights - newser.com
OPKO Health (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 580,000 Shares - MarketBeat
JPMorgan initiates Opko Health stock with Neutral rating By Investing.com - Investing.com Canada
OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance
Is OPKO Health Inc. building a consolidation baseWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
Why pension funds invest in OPKO Health Inc. (XCY) stock2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Phillip Md Et Al Frost Purchases 533,300 Shares of OPKO Health (NASDAQ:OPK) Stock - MarketBeat
Opko Health Insider Bought Shares Worth $759,115, According to a Recent SEC Filing - MarketScreener
Regression analysis insights on OPKO Health Inc. performanceDay Trade & Daily Profit Focused Screening - newser.com
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Is OPKO Health Inc. stock supported by strong fundamentalsWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
How reliable is OPKO Health Inc. (XCY) stock dividend growthGDP Growth & Reliable Intraday Trade Plans - newser.com
Will OPKO Health Inc. (XCY) stock benefit from Fed rate cuts2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Why analysts remain bullish on OPKO Health Inc. stockWall Street Watch & Stock Portfolio Risk Control - newser.com
Using Bollinger Bands to evaluate OPKO Health Inc.Recession Risk & Long-Term Capital Growth Strategies - newser.com
Opko Health Insider Bought Shares Worth $737,748, According to a Recent SEC Filing - MarketScreener
News impact scoring models applied to OPKO Health Inc.Market Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
How OPKO Health Inc. (XCY) stock performs during market turbulence2025 Macro Impact & Verified Momentum Watchlists - newser.com
Will OPKO Health Inc. stock see insider buyingQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Risk vs reward if holding onto OPKO Health Inc.Gold Moves & Low Drawdown Trading Strategies - newser.com
Opko Health CEO Phillip Frost buys $737,747 in OPK stock By Investing.com - Investing.com Nigeria
Opko Health CEO Phillip Frost buys $737,747 in OPK stock - Investing.com
Opko Health Insider Bought Shares Worth $678,906, According to a Recent SEC Filing - MarketScreener
Will OPKO Health Inc. stock benefit from green energy trendsJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference - GlobeNewswire Inc.
Will OPKO Health Inc. (XCY) stock beat growth indexesM&A Rumor & Technical Entry and Exit Alerts - newser.com
OPKO Health, Inc. $OPK Shares Sold by Y.D. More Investments Ltd - MarketBeat
Top chart patterns to watch in OPKO Health Inc.Bull Run & Low Drawdown Investment Ideas - newser.com
Is OPKO Health Inc. stock gaining market shareJuly 2025 Closing Moves & High Return Stock Watch Alerts - newser.com
Can technical indicators confirm OPKO Health Inc.’s reversalInsider Buying & Stepwise Trade Signal Guides - newser.com
Finanzdaten der Opko Health Inc-Aktie (OPK)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):